Papatheodoridis GV - Search Results

1

Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study.

Manesis EK, Papatheodoridis GV, Touloumi G, Karafoulidou A, Ketikoglou J, Kitis GE, Antoniou A, Kanatakis S, Koutsounas SJ, Vafiadis I; HEPNET.Greece Cohort Study. Manesis EK, et al. Among authors: papatheodoridis gv. Aliment Pharmacol Ther. 2009 May 15;29(10):1121-30. doi: 10.1111/j.1365-2036.2009.03974.x. Epub 2009 Feb 15. Aliment Pharmacol Ther. 2009. PMID: 19222410

2

Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.

Tassopoulos NC, Karvountzis G, Touloumi G, Delladetsima JK, Papatheodoridis GV, Katsoulidou A, Retalis G, Hatzakis A. Tassopoulos NC, et al. Among authors: papatheodoridis gv. Am J Gastroenterol. 1996 Sep;91(9):1734-8. Am J Gastroenterol. 1996. PMID: 8792690 Clinical Trial.

3

Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission.

Papatheodoridis GV, Katsoulidou A, Touloumi G, Delladetsima JK, Hatzakis A, Tassopoulos NC. Papatheodoridis GV, et al. Eur J Gastroenterol Hepatol. 1996 May;8(5):469-75. Eur J Gastroenterol Hepatol. 1996. PMID: 8804876 Clinical Trial.

4

Histopathology of chronic hepatitis C in relation to epidemiological factors.

Delladetsima JK, Rassidakis G, Tassopoulos NC, Papatheodoridis GV, Smyrnoff T, Vafiadis I. Delladetsima JK, et al. Among authors: papatheodoridis gv. J Hepatol. 1996 Jan;24(1):27-32. doi: 10.1016/s0168-8278(96)80182-6. J Hepatol. 1996. PMID: 8834021

5

Factors associated with severity and disease progression in chronic hepatitis C.

Tassopoulos NC, Papatheodoridis GV, Katsoulidou A, Delladetsima JK, Sypsa V, Touloumi G, Nikandros M, Hatzakis A. Tassopoulos NC, et al. Among authors: papatheodoridis gv. Hepatogastroenterology. 1998 Sep-Oct;45(23):1678-83. Hepatogastroenterology. 1998. PMID: 9840128

6

The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B.

Papatheodoridis GV, Manesis E, Hadziyannis SJ. Papatheodoridis GV, et al. J Hepatol. 2001 Feb;34(2):306-13. doi: 10.1016/s0168-8278(00)00094-5. J Hepatol. 2001. PMID: 11281561 Clinical Trial.

7

Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis.

Papatheodoridis GV, Papadimitropoulos VC, Hadziyannis SJ. Papatheodoridis GV, et al. Aliment Pharmacol Ther. 2001 May;15(5):689-98. doi: 10.1046/j.1365-2036.2001.00979.x. Aliment Pharmacol Ther. 2001. PMID: 11328263

8

Review article: current management of chronic hepatitis B.

Papatheodoridis GV, Hadziyannis SJ. Papatheodoridis GV, et al. Aliment Pharmacol Ther. 2004 Jan 1;19(1):25-37. doi: 10.1046/j.1365-2036.2003.01810.x. Aliment Pharmacol Ther. 2004. PMID: 14687164 Review.

9

Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.

Papatheodoridis GV, Cholongitas E. Papatheodoridis GV, et al. J Viral Hepat. 2004 Jul;11(4):287-96. doi: 10.1111/j.1365-2893.2004.00522.x. J Viral Hepat. 2004. PMID: 15230850 Review.

10

Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B.

Papatheodoridis GV, Petraki K, Cholongitas E, Kanta E, Ketikoglou I, Manesis EK. Papatheodoridis GV, et al. J Viral Hepat. 2005 Mar;12(2):199-206. doi: 10.1111/j.1365-2893.2005.00582.x. J Viral Hepat. 2005. PMID: 15720536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters